Skip to main content
Premium Trial:

Request an Annual Quote

BioChem Strikes Deal To Use Bioinformatics Technologies from SBI

Premium

SAN DIEGO--Structural Bioinformatics (SBI) here and BioChem Therapeutics, a wholly owned subsidiary of Biochem Pharma, Laval, Quebec, have agreed to collaborate on drug discovery and design using SBI's proprietary computational technologies. SBI will apply its genomics-driven, protein-structure-based drug design algorithms to facilitate the design and identification of small molecules for two targets selected by BioChem. BioChem will contribute drug development expertise, fund the research, and make milestone and royalty payments.

"We are very excited about the drug development synergy that this collaboration will create," said Edward Maggio, SBI's president and CEO. "BioChem Therapeutics' drug optimization expertise is a perfect extension of Structural Bioinformatics' computer-assisted drug design capabilities."

SBI has developed a structure-based lead discovery pathway to generate small-molecule lead compounds. The pathway relies on the company's large protein structural information database that is tightly integrated with a proprietary set of computational tools. The resulting operating system permits the identification and structural analysis of relevant sites on protein drug targets, and the direct use of this information in a variety of structure-based drug design and virtual screening applications, according to the company.

SBI, which is privately held, recently closed a new $5 million funding round.

Filed under

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.